Prescription adherence is healthcare's $289 billion problem. A data-centered approach that provides actionable insights to specialty pharma brands can ensure that therapy gets to patients quickly and efficiently, and remains in the hands of those who need it.
Traditional pharma programs have focused on creating disease and brand awareness, as well as HCP marketing to maximize the number of brand prescriptions, but today, specialty pharmacy brands face greater challenges that require improved solutions.
Often, the reason for the lag in actionability of the data is the time lag between the event itself and necessary analysis and insight. This gap is a critical barrier on targeted and effective pull-through activities.